Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
HUAXI TECHNOLOGY
872895
5
Shanghai Menon Animal Nutrition Technology
301156
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -29.84%-95.59M | 57.59%-8.9M | -458.91%-63.84M | 133.23%5.99M | -24.33%-28.83M | -83.70%-73.62M | -73.28%-20.99M | -8.94%-11.42M | -147.48%-18.02M | -127.44%-23.19M |
Net income from continuing operations | 225.18%277.45M | 288.18%481.44M | -316.16%-393.08M | 101.92%2.3M | 782.98%186.78M | -268.96%-221.64M | -1,251.90%-255.85M | 1,067.41%181.84M | -1,002.36%-120.29M | -139.11%-27.35M |
Operating gains losses | -988.86%-485.66M | -361.89%-540.26M | 239.04%332.46M | -137.72%-32.85M | -66,860.49%-245.01M | 850.74%54.64M | 14,376.47%206.3M | -8,719.54%-239.11M | 4,717.34%87.08M | -94.18%367K |
Depreciation and amortization | 112.07%6.68M | -30.92%1.7M | 1,808.99%1.7M | 518.87%1.87M | 375.68%1.41M | 242.92%3.15M | 821.72%2.46M | -61.64%89K | 30.17%302K | 58.29%296K |
Other non cash items | -2.79%65.93M | -65.97%14.54M | -23.62%14.72M | --20.18M | --16.49M | 19,058.76%67.82M | --42.72M | --19.28M | ---- | ---- |
Change In working capital | 585.73%20.12M | 230.67%27.6M | -247.02%-24.64M | 686.61%10.08M | 264.85%7.08M | -175.25%-4.14M | -618.84%-21.12M | 639.87%16.76M | -171.64%-1.72M | 160.06%1.94M |
-Change in prepaid assets | 9.15%-854K | -995.58%-1.62M | 173.08%782K | 194.32%1.09M | -162.23%-1.1M | -199.36%-940K | 23.97%181K | -263.95%-1.07M | 1,221.43%370K | -117.01%-421K |
-Change in payables and accrued expense | 861.93%23.03M | 242.59%29.65M | -248.02%-25.02M | 635.29%9.56M | 233.84%8.85M | -146.54%-3.02M | -604.59%-20.79M | 509.19%16.91M | -171.98%-1.79M | 192.05%2.65M |
-Change in other current liabilities | -1,050.84%-2.06M | 15.72%-429K | -143.01%-397K | -86.80%-566K | -130.34%-668K | 73.60%-179K | -159.69%-509K | 527.31%923K | -175.45%-303K | -85.90%-290K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -29.84%-95.59M | 57.59%-8.9M | -458.91%-63.84M | 133.23%5.99M | -24.33%-28.83M | -83.70%-73.62M | -73.28%-20.99M | -8.94%-11.42M | -147.48%-18.02M | -127.44%-23.19M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -46.86%-2.57B | 6.43%-694.61M | 47.03%-505.31M | -1,695.22%-593.64M | -3,235.67%-780.65M | -4,186.83%-1.75B | -2,385.14%-742.36M | -19,749.50%-953.97M | -935.64%-33.07M | -675.70%-23.4M |
Net PPE purchase and sale | -47.78%-2.57B | 6.28%-694.61M | 46.44%-505.31M | -1,787.89%-593.27M | -3,498.17%-774.62M | -5,048.09%-1.74B | -2,539.49%-741.17M | -30,623.35%-943.51M | -2,339.83%-31.43M | -1,538.36%-21.53M |
Net other investing changes | 57.77%-6.4M | --0 | --0 | 77.42%-371K | -221.76%-6.03M | -112.53%-15.16M | 33.43%-1.19M | -502.48%-10.45M | 13.75%-1.64M | -10.10%-1.88M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -46.86%-2.57B | 6.43%-694.61M | 47.03%-505.31M | -1,695.22%-593.64M | -3,235.67%-780.65M | -4,186.83%-1.75B | -2,385.14%-742.36M | -19,749.50%-953.97M | -935.64%-33.07M | -675.70%-23.4M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 34.50%2.77B | 35.70%830.47M | -53.92%631.87M | 1,249.76%539.34M | 2,093.45%766.39M | 1,641.19%2.06B | 13,861.50%611.97M | 1,532.13%1.37B | 39.64%39.96M | 248.81%34.94M |
Net issuance payments of debt | 18.11%2.19B | 51.50%668.11M | -64.63%498.34M | --425.67M | --592.88M | --1.85B | --441M | --1.41B | --0 | --0 |
Net common stock issuance | --0 | --0 | -285.80%-333.33M | 246.77%138.71M | 456.08%194.63M | 121.22%254.4M | --0 | 106.80%179.4M | 41.60%40M | --35M |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | 29.33%-53K | --0 | -2,200.00%-21K | 5.00%-19K | 31.58%-13K |
Proceeds from stock option exercised by employees | 30.38%-6.7M | -525.00%-125K | 32.64%-6.42M | -156.52%-59K | -100.00%-94K | -194.22%-9.63M | 95.65%-20K | ---9.54M | ---23K | 89.87%-47K |
Net other financing activities | 1,710.93%589.78M | -4.97%162.49M | --473.29M | ---24.98M | ---21.02M | -826.39%-36.61M | 4,428.96%170.99M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 34.50%2.77B | 35.70%830.47M | -53.92%631.87M | 1,249.76%539.34M | 2,093.45%766.39M | 1,641.19%2.06B | 13,861.50%611.97M | 1,532.13%1.37B | 39.64%39.96M | 248.81%34.94M |
Net cash flow | ||||||||||
Beginning cash position | 369.00%294.48M | -40.39%265.8M | 407.55%203.08M | 391.58%251.4M | 369.00%294.48M | 145.73%62.79M | 308.21%445.86M | -1.20%40.01M | 128.74%51.14M | 145.73%62.79M |
Current changes in cash | -57.58%98.28M | 183.87%126.96M | -84.55%62.72M | -334.17%-48.32M | -269.85%-43.08M | 522.20%231.69M | -226.01%-151.38M | 490.55%405.85M | -161.34%-11.13M | -264.68%-11.65M |
End cash Position | 33.38%392.76M | 33.38%392.76M | -40.39%265.8M | 407.55%203.08M | 391.58%251.4M | 369.00%294.48M | 369.00%294.48M | 308.21%445.86M | -1.20%40.01M | 128.74%51.14M |
Free cash flow | -47.05%-2.66B | 7.70%-703.51M | 40.40%-569.15M | -1,087.78%-587.28M | -1,696.88%-803.44M | -2,353.31%-1.81B | -1,796.16%-762.16M | -6,943.87%-954.94M | -477.01%-49.44M | -288.54%-44.71M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |